Answers are grounded in this paper and cite their sources.
To the Editors: We report a 7-year-old male child with T-cell preacute lymphoblastic leukemia who presented with vomiting, abdominal pain, distension and organomegaly 6 months after diagnosis. He had a prolonged hospital stay in the pediatric intensive care unit because of multiorgan failure, typhlitis and need for cardiorespiratory support. Epstein-Barr virus–related hemophagocytic lymphohistiocytosis was diagnosed, and long-term steroid treatment was initiated. Moderate dysphagia was found on a swallow study obtained because of poor oral intake. The dysphagia was attributed to prolonged nasogastric tube use prompting the placement of a balloon type gastrostomy tube (G-tube). Two months after placement, the patient presented with erythema and pain at the site of the G-tube. The initial erythema around the G-tube site was mild with noted granulation tissue and a small ulcer with clear yellow drainage. Ultrasound examination of the G-tube site showed hypoechoic soft tissues, thought to be granulation tissue. Superficial cultures from the peristomal area grew Enterococcus faecalis, Pseudomonas aeruginosa and Candida albicans, and he was treated with broad-spectrum antibiotics and antifungals. He appeared to have a good clinical response and was asymptomatic after neutrophil recovery. During the next 6 months, increasing pain and erythema were present at the peristomal site with ensuing episodes of neutropenia after chemotherapy. Because of the recurrent nature of the peristomal process, mycobacterial cultures were obtained from the G-tube site. After 5 days of incubation, a rapid growing mycobacterium, subsequently confirmed to be Mycobacterium chelonae, was identified. The G-tube was removed, and tissue biopsy was performed. Histopathology showed fibrosis and chronic inflammation and culture grew M. chelonae after 11 days. The rate of wound healing after removal of the tube was poor, and an abscess was noted on top of the weakly formed granulation tissue. The abscess ruptured a week into his postoperative course revealing a crater-like wound that drained copious purulent material. Improvement followed after initiation of nontuberculous mycobacterial (NTM) therapy. The organism was susceptible to amikacin, clarithromycin, linezolid and tobramycin. Intermediate susceptibility was found to fluoroquinolones and imipenem, and resistance was noted for cephalosporins, meropenem, minocycline and trimethoprim–sulfamethoxazole. A 4-drug antibiotic regimen was initiated with linezolid, azithromycin, ciprofloxacin and amikacin. Amikacin was discontinued after 1 month. Infection caused by NTM has been reported in association with several surgical procedures, most often after sternotomy or cosmetic surgical procedures.1–3 NTM infections after surgical procedures are generally related to the use of colonized aqueous solutions or to inadequate sterilization or disinfection of surgical equipment, particularly in the cases of endoscopy equipment.4,5 Infections have followed a variety of cardiovascular, ocular, breast and abdominal surgeries, and 1 case after repair of a ventral hernia using synthetic mesh.5 To our knowledge, this is the first report of peristomal infection with M. chelonae and underscores the importance of considering NTM as a cause of recalcitrant peristomal infection. In individuals with chemotherapy-associated neutropenia, clinical findings may initially be subtle and improve during periods of neutrophil recovery. As with other cases of foreign body–related infections, removal of the foreign body is crucial for successful treatment. In cases where peristomal infection is recurrent, NTM should be considered, and the addition of mycobacterial cultures will confirm the diagnosis. Amr Nabaah, MBBS Pediatrics Department University of Kansas School of Medicine Kansas City, Kansas Mary Anne Jackson, MD Division of Infectious Diseases Children’s Mercy Hospital and Clinics Kansas City, Missouri University of Missouri-Kansas City School of Medicine Kansas City, Missouri Angela Myers, MD, MPH Infectious Diseases Fellowship Program University of Missouri-Kansas City School of Medicine Kansas City, Missouri Jyoti Panicker, MD Division of Pediatric Hematology Oncology University of Kansas School of Medicine Kansas City, Kansas
No takes yet. Share an insight, caveat, or question.
Nabaah et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: